Keyphrases
Radiation Therapy
100%
Erythropoietin
100%
Cervical Cancer
100%
Hemoglobin
100%
RhEPO
77%
Historical Controls
44%
Anemia
33%
Deep Vein Thrombosis
22%
External Beam Radiotherapy
22%
Ferrous Sulfate
22%
Phase II Study
11%
Randomized Trial
11%
Chemotherapy
11%
Poor Outcome
11%
Means of Control
11%
Local Control
11%
No Significant Difference
11%
Platelet Count
11%
Blood Pressure Changes
11%
Red Blood Cell Transfusion
11%
FIGO Stage
11%
White Blood Count
11%
Intracavitary
11%
Concurrent Control
11%
Cis-platinum
11%
Stage IB
11%
Cesium
11%
Reticulocytosis
11%
Radiosensitization
11%
Local Survival
11%
Cervical Cancer Patients
11%
Toxicity Issues
11%
Radiation Chemotherapy
11%
Erythropoietin Therapy
11%
Nursing and Health Professions
Uterine Cervix Cancer
100%
Erythropoietin
100%
Radiotherapy
100%
Procrit
77%
Anemia
33%
Ferrous Sulfate
22%
Deep Vein Thrombosis
22%
External Beam Radiotherapy
22%
Radiosensitizing Agent
11%
Leukocyte Count
11%
Platelet Count
11%
Blood Pressure
11%
Cesium
11%
Reticulocytosis
11%
Cisplatin
11%
Efficacy
11%
Side Effect
11%
Medicine and Dentistry
Cervical Cancer
100%
Erythropoietin
100%
Radiation Therapy
100%
Recombinant Erythropoietin
77%
Anemia
33%
External Beam Radiotherapy
22%
Deep Vein Thrombosis
22%
Ferrous Sulfate
22%
Platelet
11%
Blood Pressure
11%
Reticulocytosis
11%
Radiosensitizer
11%
Cesium
11%
Cisplatin
11%
Side Effect
11%
Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Cancer
100%
Recombinant Erythropoietin
100%
Erythropoietin
100%
Anemia
42%
Chemotherapy
28%
Ferrous Sulfate
28%
Deep Vein Thrombosis
28%
Cisplatin
14%
Radiosensitizing Agent
14%
Cesium
14%
Reticulocytosis
14%
Side Effect
14%